• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伪激酶的新作用

Emerging roles of pseudokinases.

作者信息

Boudeau Jérôme, Miranda-Saavedra Diego, Barton Geoffrey J, Alessi Dario R

机构信息

MRC Protein Phosphorylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH , UK.

出版信息

Trends Cell Biol. 2006 Sep;16(9):443-52. doi: 10.1016/j.tcb.2006.07.003. Epub 2006 Aug 1.

DOI:10.1016/j.tcb.2006.07.003
PMID:16879967
Abstract

Kinases control virtually all aspects of biology. Forty-eight human proteins have a kinase-like domain that lacks at least one of the conserved catalytic residues; these proteins are therefore predicted to be inactive and have been termed pseudokinases. Here, we describe exciting work suggesting that pseudokinases, despite lacking the ability to phosphorylate substrates, are still pivotal in regulating diverse cellular processes. We review evidence that the pseudokinase STRAD controls the function of the tumour suppressor kinase LKB1 and that a single amino acid substitution within the pseudokinase domain of the tyrosine kinase JAK2 leads to several malignant myeloproliferative disorders. We also discuss the emerging functions of other pseudokinases, including HER3 (also called ErbB3), EphB6, CCK4 (also called PTK7), KSR, Trb3, GCN2, TRRAP, ILK and CASK.

摘要

激酶几乎控制着生物学的所有方面。48种人类蛋白质具有激酶样结构域,但至少缺少一个保守的催化残基;因此,这些蛋白质预计是无活性的,被称为假激酶。在此,我们描述了一项令人兴奋的研究工作,表明假激酶尽管缺乏磷酸化底物的能力,但在调节多种细胞过程中仍然至关重要。我们综述了相关证据,即假激酶STRAD控制肿瘤抑制激酶LKB1的功能,以及酪氨酸激酶JAK2的假激酶结构域内的单个氨基酸取代会导致几种恶性骨髓增殖性疾病。我们还讨论了其他假激酶的新功能,包括HER3(也称为ErbB3)、EphB6、CCK4(也称为PTK7)、KSR、Trb3、GCN2、TRRAP、ILK和CASK。

相似文献

1
Emerging roles of pseudokinases.伪激酶的新作用
Trends Cell Biol. 2006 Sep;16(9):443-52. doi: 10.1016/j.tcb.2006.07.003. Epub 2006 Aug 1.
2
ATP and MO25alpha regulate the conformational state of the STRADalpha pseudokinase and activation of the LKB1 tumour suppressor.三磷酸腺苷(ATP)和MO25α调节STRADα伪激酶的构象状态以及抑癌基因LKB1的激活。
PLoS Biol. 2009 Jun 9;7(6):e1000126. doi: 10.1371/journal.pbio.1000126.
3
Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD.由类STE20假激酶STRAD激活肿瘤抑制激酶LKB1。
EMBO J. 2003 Jun 16;22(12):3062-72. doi: 10.1093/emboj/cdg292.
4
BCR/ABL-negative chronic myeloproliferative disorders: JAK2 mutation and beyond.BCR/ABL阴性慢性骨髓增殖性疾病:JAK2突变及其他相关情况。
Arch Pathol Lab Med. 2006 Aug;130(8):1123-5. doi: 10.5858/2006-130-1123-ACMD.
5
Myeloproliferative disorders carrying the t(8;9) (PCM1-JAK2) translocation.携带t(8;9)(PCM1-JAK2)易位的骨髓增殖性疾病。
Hum Pathol. 2006 Apr;37(4):500; author reply 500-2. doi: 10.1016/j.humpath.2005.12.002. Epub 2006 Feb 3.
6
Detection of the single hotspot mutation in the JH2 pseudokinase domain of Janus kinase 2 in bone marrow trephine biopsies derived from chronic myeloproliferative disorders.在源自慢性骨髓增殖性疾病的骨髓活检组织中检测Janus激酶2的JH2假激酶结构域中的单一热点突变。
J Mol Diagn. 2006 May;8(2):170-7. doi: 10.2353/jmoldx.2006.050064.
7
Diagnostic assays for the JAK2 V617F mutation in chronic myeloproliferative disorders.慢性骨髓增殖性疾病中JAK2 V617F突变的诊断检测方法。
Am J Clin Pathol. 2006 May;125(5):651-3. doi: 10.1309/NXXT-GRCX-D0TM-A3C2.
8
Allosteric protein kinase regulation by pseudokinases: insights from STRAD.别构蛋白激酶的调节:来自 STRAD 的见解。
Sci Signal. 2010 Mar 2;3(111):pe8. doi: 10.1126/scisignal.3111pe8.
9
[A recurrent mutation of the JAK2 gene in chronic myeloproliferative disorders].慢性骨髓增殖性疾病中JAK2基因的复发性突变
Pathol Biol (Paris). 2006 May;54(4):182-4. doi: 10.1016/j.patbio.2005.07.002. Epub 2005 Aug 3.
10
The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disorders.V617F JAK2突变在癌症及除经典骨髓增殖性疾病外的髓系恶性肿瘤中并不常见。
Blood. 2005 Oct 15;106(8):2920-1. doi: 10.1182/blood-2005-05-2087.

引用本文的文献

1
Tribbles 3 blunts exercise-induced skeletal muscle adaptation.Tribbles 3会削弱运动诱导的骨骼肌适应性。
bioRxiv. 2025 Jul 19:2025.07.16.665065. doi: 10.1101/2025.07.16.665065.
2
NRBP1 pseudokinase binds to and activates the WNK pathway in response to osmotic stress.NRBP1假激酶在渗透压应激反应中与WNK通路结合并激活该通路。
Sci Adv. 2025 Jul 18;11(29):eadv4636. doi: 10.1126/sciadv.adv4636. Epub 2025 Jul 16.
3
MLKL as an emerging machinery for modulating organelle dynamics: regulatory mechanisms, pathophysiological significance, and targeted therapeutics.
混合谱系激酶结构域样蛋白(MLKL)作为一种调节细胞器动态变化的新兴机制:调控机制、病理生理学意义及靶向治疗
Front Pharmacol. 2025 Feb 25;16:1512968. doi: 10.3389/fphar.2025.1512968. eCollection 2025.
4
Development of a novel anti-erythropoietin-producing hepatocellular receptor B6 monoclonal antibody EbMab-3 for flow cytometry.用于流式细胞术的新型抗促红细胞生成素产生肝细胞受体B6单克隆抗体EbMab-3的研发
Biochem Biophys Rep. 2025 Feb 21;41:101960. doi: 10.1016/j.bbrep.2025.101960. eCollection 2025 Mar.
5
Potential biomarkers and immune infiltration linking endometriosis with recurrent pregnancy loss based on bioinformatics and machine learning.基于生物信息学和机器学习的子宫内膜异位症与复发性流产相关的潜在生物标志物及免疫浸润
Front Mol Biosci. 2025 Feb 3;12:1529507. doi: 10.3389/fmolb.2025.1529507. eCollection 2025.
6
Current understanding of PEAK family members in regulation of cellular signaling pathways and cancer therapy.目前对PEAK家族成员在细胞信号通路调控和癌症治疗方面的理解。
Mol Cell Biochem. 2025 Jun;480(6):3521-3533. doi: 10.1007/s11010-025-05219-w. Epub 2025 Feb 8.
7
The receptor MIK2 interacts with the kinase RKS1 to control quantitative disease resistance to Xanthomonas campestris.受体MIK2与激酶RKS1相互作用,以控制对野油菜黄单胞菌的定量抗病性。
Plant Physiol. 2024 Dec 23;197(1). doi: 10.1093/plphys/kiae626.
8
Decoding the secret of extracellular vesicles in the immune tumor microenvironment of the glioblastoma: on the border of kingdoms.解析胶质母细胞瘤免疫肿瘤微环境中外泌体的秘密:在王国的边界上。
Front Immunol. 2024 Aug 29;15:1423232. doi: 10.3389/fimmu.2024.1423232. eCollection 2024.
9
HER3-targeted therapeutic antibodies and antibody-drug conjugates in non-small cell lung cancer refractory to EGFR-tyrosine kinase inhibitors.针对HER3的治疗性抗体及抗体药物偶联物在对EGFR酪氨酸激酶抑制剂耐药的非小细胞肺癌中的应用
Chin Med J Pulm Crit Care Med. 2023 Feb 27;1(1):11-17. doi: 10.1016/j.pccm.2022.12.001. eCollection 2023 Mar.
10
NRBP1 promotes malignant phenotypes of glioblastoma by regulating PI3K/Akt activation.NRBP1 通过调控 PI3K/Akt 激活促进胶质母细胞瘤的恶性表型。
Cancer Med. 2024 Aug;13(16):e70100. doi: 10.1002/cam4.70100.